Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 11:12:877995.
doi: 10.3389/fcimb.2022.877995. eCollection 2022.

Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis

Affiliations
Review

Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis

Maria Eduarda Souza Guerra et al. Front Cell Infect Microbiol. .

Erratum in

Abstract

The ability to form biofilms is a crucial virulence trait for several microorganisms, including Klebsiella pneumoniae - a Gram-negative encapsulated bacterium often associated with nosocomial infections. It is estimated that 65-80% of bacterial infections are biofilm related. Biofilms are complex bacterial communities composed of one or more species encased in an extracellular matrix made of proteins, carbohydrates and genetic material derived from the bacteria themselves as well as from the host. Bacteria in the biofilm are shielded from immune responses and antibiotics. The present review discusses the characteristics of K. pneumoniae biofilms, factors affecting biofilm development, and their contribution to infections. We also explore different model systems designed to study biofilm formation in this species. A great number of factors contribute to biofilm establishment and maintenance in K. pneumoniae, which highlights the importance of this mechanism for the bacterial fitness. Some of these molecules could be used in future vaccines against this bacterium. However, there is still a lack of in vivo models to evaluate the contribution of biofilm development to disease pathogenesis. With that in mind, the combination of different methodologies has great potential to provide a more detailed scenario that more accurately reflects the steps and progression of natural infection.

Keywords: Klebsiella pneumoniae; biofilm; pathogenesis; quorum sensing; virulence factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Factors contributing to K. pneumoniae biofilm formation. Polysaccharide capsule, LPS, fimbriae, pili, iron metabolism and, quorum sensing. *Molecules related to siderophores.

Similar articles

Cited by

References

    1. Abraham W. R. (2016). Going Beyond the Control of Quorum-Sensing to Combat Biofilm Infections. Antibiot. (Basel). 5 (1), 1–16. doi: 10.3390/antibiotics5010003 - DOI - PMC - PubMed
    1. Abraham J. M., Freitag C. S., Clements J. R., Eisenstein B. I. (1985). An Invertible Element of DNA Controls Phase Variation of Type 1 Fimbriae of Escherichia Coli. Proc. Natl. Acad. Sci. U.S.A. 82 (17), 5724–5727. doi: 10.1073/pnas.82.17.5724 - DOI - PMC - PubMed
    1. Alcantar-Curiel M. D., Blackburn D., Saldana Z., Gayosso-Vazquez C., Iovine N. M., de la Cruz M. A., et al. . (2013). Multi-Functional Analysis of Klebsiella Pneumoniae Fimbrial Types in Adherence and Biofilm Formation. Virulence 4 (2), 129–138. doi: 10.4161/viru.22974 - DOI - PMC - PubMed
    1. Ares M. A., Fernandez-Vazquez J. L., Rosales-Reyes R., Jarillo-Quijada M. D., von Bargen K., Torres J., et al. . (2016). H-NS Nucleoid Protein Controls Virulence Features of Klebsiella Pneumoniae by Regulating the Expression of Type 3 Pili and the Capsule Polysaccharide. Front. Cell Infect. Microbiol. 6, 13. doi: 10.3389/fcimb.2016.00013 - DOI - PMC - PubMed
    1. Assoni L., Girardello R., Converso T. R., Darrieux M. (2021). Current Stage in the Development of Klebsiella Pneumoniae Vaccines. Infect. Dis. Ther. 10 (4), 2157–2175. doi: 10.1007/s40121-021-00533-4 - DOI - PMC - PubMed

Publication types

Substances